Assessing the E2 Receptor Assay for Breast Tumors
Author Information
Author(s): D.W. Wilson, G. Richards, R.I. Nicholson, K. Griffiths
Primary Institution: Tenovus Institute for Cancer Research, Welsh National School of Medicine
Hypothesis
How do methodological errors affect the accuracy of the E2 receptor assay in breast tumors?
Conclusion
The Mass Action model is superior for estimating receptor concentrations in breast tumor cytosol compared to the Scatchard model.
Supporting Evidence
- The Mass Action model provided lower estimates of receptor concentrations in most cases compared to the Scatchard model.
- Computer simulations indicated that the Mass Action model is more reliable under conditions of high uncertainty.
- Practical data showed that the minimum detectable receptor concentration can be significantly affected by methodological errors.
Takeaway
This study looks at how to measure hormone receptors in breast cancer better, showing one method works better than another.
Methodology
The study used practical and computer simulated data analyzed by Scatchard and Mass Action models to evaluate the receptor assay.
Potential Biases
Potential biases arise from misclassification of receptor status due to methodological inefficiencies.
Limitations
The study's findings may not apply universally due to variations in non-specific binding and other methodological errors.
Participant Demographics
Breast tumor samples from patients undergoing surgery.
Statistical Information
Confidence Interval
0 to 16 fmol mg-1 protein
Want to read the original?
Access the complete publication on the publisher's website